Stock Events

Stock Events

Search...

Regeneron Pharmaceuticals (REGN) Q2 2024 Earnings

2MayConfirmed

Q3 2023

Q4 2023

Q1 2024

Q2 2024

9.55

10.32

11.09

11.86

Details

Expected EPS

10.171044

Actual EPS

9.55

Surprise EPS

-0.62

Surprise Percent

+6.11%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 9.55 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.